We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
AUM
$132M
AUM Growth
-$1M
Cap. Flow
-$50.9M
Cap. Flow %
-38.52%
Top 10 Hldgs %
64.22%
Holding
198
New
26
Increased
36
Reduced
14
Closed
106

Sector Composition

Rank Sector Weight
1 Technology 11.19%
2 Healthcare 3.67%
3 Industrials 1.57%
4 Consumer Discretionary 0.76%
5 Communication Services 0.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATTU
26
DELISTED
Attunity Ltd
ATTU
$560K 0.42%
28,504
-1,200
-4% -$22.8K
XLI icon
27
State Street Industrial Select Sector SPDR ETF
XLI
$32.7B
$553K 0.42%
8,607
+1,860
+28% +$132K
XLF icon
28
State Street Financial Select Sector SPDR ETF
XLF
$56.8B
$446K 0.34%
18,769
+3,782
+25% +$98.2K
KN icon
29
Knowles
KN
$2.99B
$437K 0.33%
32,838
-1,400
-4% -$20.5K
QUIK icon
30
QuickLogic
QUIK
$217M
$434K 0.33%
42,341
+25,912
+158% +$334K
BNGO icon
31
Bionano Genomics
BNGO
$12.6M
$417K 0.32%
133
+125
+1,563% +$498K
LTRX icon
32
Lantronix
LTRX
$233M
$414K 0.31%
142,500
+47,500
+50% +$161K
CLFD icon
33
Clearfield
CLFD
$414M
$413K 0.31%
41,647
-1,800
-4% -$21.4K
SMTC icon
34
Semtech
SMTC
$10.1B
$394K 0.3%
8,601
-6,972
-45% -$332K
ALLT icon
35
Allot
ALLT
$372M
$390K 0.3%
64,375
-2,800
-4% -$18.3K
DMAC icon
36
DiaMedica Therapeutics
DMAC
$363M
$377K 0.29%
+129,863
New +$408K
APEN
37
DELISTED
Apollo Endosurgery, Inc.
APEN
$368K 0.28%
107,000
+57,000
+114% +$281K
DSPG
38
DELISTED
DSP Group Inc
DSPG
$351K 0.27%
31,389
+1,640
+6% +$19.2K
QCOM icon
39
PUT
Qualcomm
QCOM
$170B
$348K 0.26%
+91,900
New +$5.58M
XLP icon
40
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
$347K 0.26%
+6,863
New +$372K
QMCO icon
41
Quantum Corp
QMCO
$475M
$336K 0.25%
+8,425
New +$387K
PGNX
42
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$318K 0.24%
76,200
+61,200
+408% +$312K
XPH icon
43
State Street SPDR S&P Pharmaceuticals ETF
XPH
$484M
$310K 0.23%
8,502
+3,871
+84% +$165K
WPRT
44
Westport Fuel Systems
WPRT
$32.7M
$265K 0.2%
20,000
+10,000
+100% +$226K
NEOS
45
DELISTED
Neos Therapeutics, Inc
NEOS
$248K 0.19%
150,586
+130,586
+653% +$366K
OSS icon
46
One Stop Systems
OSS
$291M
$232K 0.18%
120,000
+45,000
+60% +$128K
XLC icon
47
State Street Communication Services Select Sector SPDR ETF
XLC
$22.5B
$221K 0.17%
+5,388
New +$241K
INSM icon
48
PUT
Insmed
INSM
$22.7B
$206K 0.16%
95,500
+19,100
+25% +$305K
TPST icon
49
Tempest Therapeutics
TPST
$14.1M
$206K 0.16%
133
+97
+269% +$200K
RIGL icon
50
Rigel Pharmaceuticals
RIGL
$715M
$200K 0.15%
8,740
+7,740
+774% +$218K

Similar funds

Worth Venture Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Worth Venture Partners held 198 positions worth $132M, down 0.75% from $133M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Worth Venture Partners withdrew a net $50.9M in Q4 2018, closing 106 positions and reducing 14 holdings. Its most notable exit was NXP Semiconductors, an estimated $3.52M position sold in full.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Worth Venture Partners opened a new position in Qualcomm worth $3.84M.

  • Worth Venture Partners's largest Q4 2018 buy was Qualcomm: 67,444 shares worth $3.84M.
  • Worth Venture Partners added most to iShares Russell 2000 ETF in Q4 2018, an estimated $1.56M increase.
  • Worth Venture Partners's biggest Q4 2018 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.56M.
  • Worth Venture Partners fully exited NXP Semiconductors in Q4 2018, selling an estimated $3.52M.
  • Worth Venture Partners's ten largest holdings make up 64% of its $132M portfolio in Q4 2018.
  • Worth Venture Partners opened 26 new positions and closed 106 in Q4 2018.
  • Worth Venture Partners's portfolio value fell 0.75% quarter-over-quarter to $132M.

Based on Worth Venture Partners's 13F filing for Q4 2018, filed 15 Feb 2019.